Plastic and Reconstructive Surgery, Global Open (Jun 2024)

Surgical Management of Hidradenitis Suppurativa

  • Aleksandra Krajewski, MD,
  • Ahmed Alsayed, MD,
  • Allison Capek, PA-C,
  • Kathleen Casey, PA-C,
  • Rajiv Chandawarkar, MD, MBA

DOI
https://doi.org/10.1097/GOX.0000000000005860
Journal volume & issue
Vol. 12, no. 6
p. e5860

Abstract

Read online

Hidradenitis suppurativa (HS) is a chronic, relapsing inflammatory disease of the skin, characterized by recurrent draining sinuses and abscesses, predominantly in skin folds carrying terminal hairs and apocrine glands. Treatment for this debilitating disease has been medical management with antibiotics and immune modulators. With the advent of better reconstructive surgical techniques, the role of surgery in the treatment of HS has expanded, from being a last resort to a modality that is deployed earlier. Larger defects can be more easily reconstructed, allowing for a more radical excision of diseased areas. Locoregional flaps, perforator flaps, and propeller flaps that use the fasciocutaneous tissue allow reconstruction of defects with similar tissue, and provide better cosmetic and functional outcomes. They are easy to execute and can be performed even in resource-poor settings with concurrent use of immune modulators and postoperative antibiotics. Hidradenitis can be successfully treated with surgery in early stages as well as severe disease, due to the advances in understanding disease behavior, multidisciplinary care, and advanced reconstructive techniques. Coupled with a multidisciplinary care team, surgery offers a durable, lasting cure for HS, significantly reducing disease morbidity.